Glycation‐Driven Impairment of Cytoskeletal Homeostasis and Viability Disables Glyoxalase‐Low Mesothelia From Resisting Cancer Colonization
Journal of Cellular Physiology · 2026
DOI: 10.1002/jcp.70123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2026. Verfasst von Satyarthi Mishra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Nano Science and Engineering, Indian Institute of Science, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Lactoylglutathione Lyase, Cytoskeleton, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Wellcome Trust/DBT India Alliance, John Templeton Foundation, Indo-French Centre.
Abstract (Originalsprache)
Chronic metabolic disorders and aging cause accumulation of dicarbonyls that glycate and render biomolecules dysfunctional. Although systemic metabolic dysregulation is associated with faster cancer progression, their mechanistic determinants remain elusive. We move between time‐lapse and end‐point experiments and tissue‐scale simulations to build a systems model of ovarian cancer colonization and show that confluent healthy serosal mesothelia can stall spheroidal adhesion and spread. However, mesothelial clearance by spheroids continues under increasing concentrations of the dicarbonyl methylglyoxal (MG). High MG levels glycate mesothelia and destabilize their adhesion and motility through mislocalization of F‐actin, ezrin, and ZO‐1. This explains preferential spheroidal spreading amidst sub‐confluent mesothelia. Confluence is dependent on mesothelial viability, which is also decreased by MG. Intriguingly, cancer cells escape glycation and its cytopathological effects by expressing relatively higher levels of glyoxalase 1 (GLO1); pharmacological GLO1 inhibition renders cancer cells vulnerable to MG. Thus, inhibition of stromal glycation holds promise for incorporation into personalized oncotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Nano Science and Engineering, Indian Institute of Science, Bengaluru, Karnataka, India.
- Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, Karnataka, India.
- IISc Mathematics Initiative, Indian Institute of Science, Bangalore, Karnataka, India.
- Sri Shankara Cancer Hospital and Research Centre, Bengaluru, Karnataka, India.
- Department of Bioengineering, Indian Institute of Science, Bengaluru, Karnataka, India.
ORCID-Profile: Satyarthi Mishra, Chigicherla V S Prasanna, Ramray Bhat
Förderung
- Wellcome Trust/DBT India Alliance
- John Templeton Foundation
- Indo-French Centre
Zitieren
APA
Mishra, S., Vidhipriya, K., Gopikrishnan, A., Sarkar, P., Mishra, S., Prasanna, C. V. S., Hari, P. S., Korlimarla, A., Sen, P., & Bhat, R. (2026). Glycation‐Driven Impairment of Cytoskeletal Homeostasis and Viability Disables Glyoxalase‐Low Mesothelia From Resisting Cancer Colonization. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70123
Vancouver
Mishra S, Vidhipriya K, Gopikrishnan A, Sarkar P, Mishra S, Prasanna CVS, et al. Glycation‐Driven Impairment of Cytoskeletal Homeostasis and Viability Disables Glyoxalase‐Low Mesothelia From Resisting Cancer Colonization. Journal of Cellular Physiology. 2026. doi:10.1002/jcp.70123
BibTeX
@article{Mishra2026,
author = {Mishra, Satyarthi and Vidhipriya, Kottpalli and Gopikrishnan, Anchita and Sarkar, Purba and Mishra, Sudiksha and Prasanna, Chigicherla V S and Hari, P S and Korlimarla, Aruna and Sen, Prosenjit and Bhat, Ramray},
title = {Glycation‐Driven Impairment of Cytoskeletal Homeostasis and Viability Disables Glyoxalase‐Low Mesothelia From Resisting Cancer Colonization},
journal = {Journal of Cellular Physiology},
year = {2026},
doi = {10.1002/jcp.70123}
}
EUVIMED